VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CLS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CLSCelestica Inc.
$340.40$39.1B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLSBalance Sheet

Celestica Inc. (CLS) Balance Sheet

29Y historyFree accessUpdated daily

Total assets surged 58% YoY to $9.8B, with PPE up 39% sequentially to $1.2B, while debt-to-equity remains low at 0.33, though the current ratio has thinned to 1.23.

CLS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Total Current Assets7.57B5.66B4.51B4.51B4.33B3.44B2.74B2.59B2.82B2.48B2.37B2.12B2.1B2.12B2.11B2.46B2.53B2.54B3.17B3B3.12B3.26B3.27B3.03B3.56B4B4.52B1.85B982.9M830.8M
Cash & Short-Term Investments535.7M594.52M423.3M370.4M374.5M394M463.8M479.5M422M515.2M557.2M545.3M565M544.3M550.5M658.9M632.8M937.7M1.2B1.12B803.7M969M968.8M1.03B1.85B1.34B883.76M371.5M31.7M106.01M
Cash Only535.7M594.52M423.3M370.4M374.5M394M463.8M479.5M422M515.2M557.2M545.3M565M544.3M550.5M658.9M632.8M937.7M1.2B1.12B803.7M969M968.8M1.03B1.85B1.34B883.76M371.5M31.7M105.2M
Short-Term Investments000000000000000000000000000000
Accounts Receivable3.34B2.63B2.08B1.8B1.39B1.26B1.09B1.05B1.21B1.02B1.02B681M693.5M654.1M714.3M819.9M960.7M849.3M1.09B941.2M973.2M982.6M1.02B771.5M785.9M1.05B1.79B700.8M463M372.1M
Days Sales Outstanding67.6476.2378.6182.3370.1681.6469.4365.2566.3960.8361.4144.0844.9541.1940.0741.4953.7350.8851.7342.5740.3142.3442.2541.8134.6838.4666.8448.2952.0167.75
Inventory3.4B2.18B1.76B2.1B2.35B1.7B1.09B992.2M1.09B824M684.4M794.6M719M817.2M745.7M880.7M845.7M676.1M787.4M791.9M1.2B1.06B1.06B1.03B775.6M1.37B1.66B722.3M430.9M312.9M
Days Inventory Outstanding68.1171.674.62106.57129.97120.3375.0265.864.1452.5444.4755.2650.2255.1744.8547.850.7543.5840.2137.7952.348.3546.0158.0936.6953.9267.0254.4352.8361.96
Other Current Assets298.7M251.04M250.8M238M208.7M84M88.5M67.6M105M113.7M108.2M103.1M126.7M104.9M100.2M103.1M5.2M5.2M8.2M23.6M35M124.4M90.9M40.8M36.9M49.7M187.19M56.7M57.3M40.6M
Total Non-Current Assets2.21B1.54B1.48B1.38B1.3B1.23B926.9M968.7M914.2M487.6M474.7M488M479.4M518.4M548.1M507M572.2M563.3M614.4M1.47B1.57B1.6B1.67B2.1B2.24B2.64B1.42B804.3M653.5M515.6M
Property, Plant & Equipment1.18B708.81M661.6M631.8M510.3M452.5M433.5M459.1M365.3M323.9M302.7M314.6M312.4M313.6M337M322.7M368.7M393.8M467.5M466M567.1M544.8M569.3M679.6M727.8M915.1M633.44M365.4M214.9M124.2M
Fixed Asset Turnover18.24x17.79x14.58x12.60x14.21x12.45x13.26x12.83x18.16x18.96x19.98x17.92x18.03x18.48x19.31x22.35x17.70x15.47x16.42x17.32x15.54x15.55x15.53x9.91x11.37x10.93x15.40x14.50x15.12x16.14x
Goodwill332.9M332.49M340.5M321.7M321.8M324.2M198.6M198.3M198.4M23.2M23.2M19.5M19.5M60.3M60.3M48M11M00850.5M854.8M874.5M00000000
Intangible Assets244.9M265.72M314.6M325.2M353.8M390.9M238.7M261M293.7M32.1M25.5M41.8M47M56.4M65.6M35.5M33M32.3M20.1M35.2M60.1M79M977.4M1.09B1.16B1.56B578.27M367.6M374.5M352.3M
Long-Term Investments12.58M12.58M9.7M000000000000000000000000000
Other Non-Current Assets250.3M61.39M61.9M101.2M115.1M64M56.1M50.3M56.8M108.4M123.3M112.1M100.5M88.1M48.6M59.4M159.5M137.2M126.8M119.2M83.5M096.1M339.1M354.6M165.2M205.31M71.3M64.1M39.1M
Total Assets9.79B7.2B5.99B5.89B5.63B4.67B3.66B3.56B3.74B2.96B2.84B2.61B2.58B2.64B2.66B2.97B3.1B3.11B3.79B4.47B4.69B4.86B4.94B5.13B5.81B6.63B5.94B2.66B1.64B1.35B
Asset Turnover1.96x1.75x1.61x1.35x1.29x1.21x1.57x1.65x1.77x2.07x2.13x2.16x2.18x2.20x2.45x2.43x2.10x1.96x2.03x1.81x1.88x1.74x1.79x1.31x1.42x1.51x1.64x1.99x1.99x1.49x
Asset Growth %130.09%20.24%1.66%4.66%20.59%27.37%2.9%-4.74%26.09%4.3%8.8%1.1%-2.1%-0.75%-10.47%-4.32%-0.08%-17.96%-15.31%-4.6%-3.53%-1.66%-3.8%-11.57%-12.45%11.7%123.6%62.28%21.54%-
Total Current Liabilities6.18B3.93B3.02B3.22B3.06B2.25B1.58B1.48B1.62B1.27B1.25B1.13B1.05B1.11B1.2B1.35B1.56B1.52B1.57B1.45B1.73B1.77B1.81B1.52B1.47B1.66B2.26B851.1M626.7M467.6M
Accounts Payable3.82B1.86B1.29B1.3B1.44B1.24B854.5M898M1.13B931.1M876.9M801.4M730.9M770.7M831.6M1B1.18B927.1M1.09B1.03B1.19B1.15B1.11B1.1B947.2M1.2B2.25B613.1M428.5M445.14M
Days Payables Outstanding69.0661.0654.8865.7579.6887.858.7359.5666.359.3756.9855.7451.0552.0350.0254.4270.5959.7655.749.1552.1152.6947.9662.1144.847.0790.5846.252.5488.14
Short-Term Debt26.4M57.5M26.5M17.4M17.1M17M67.6M111.2M104.5M26.8M56M29.1M0055M00222.8M1M200K600K500K126.7M2.7M2.7M10M1.36M2.7M2.3M15.86M
Deferred Revenue (Current)0000000000000000038M13.7M402.6M489M496.6M487.2M403.7M496.9M427.5M0000
Other Current Liabilities2.33B1.57B19.9M998.8M939.3M519.6M251.6M250.4M139.7M67.8M51.1M72M63.8M64M30.8M36.3M203.9M234.7M317.3M14M383.1M398.6M93.8M29.6M46M42.8M7.7M235.3M195.9M6.59M
Current Ratio1.23x1.44x1.49x1.40x1.42x1.52x1.73x1.75x1.74x1.96x1.90x1.87x2.00x1.91x1.76x1.83x1.62x1.67x2.02x2.07x1.81x1.84x1.80x2.00x2.42x2.41x2.00x2.18x1.57x1.78x
Quick Ratio0.68x0.88x0.91x0.75x0.65x0.77x1.04x1.08x1.07x1.30x1.35x1.17x1.31x1.17x1.14x1.17x1.08x1.23x1.52x1.53x1.11x1.24x1.22x1.32x1.90x1.58x1.26x1.33x0.88x1.11x
Cash Conversion Cycle66.786.7798.35123.16120.45114.1685.7271.564.235448.9143.6144.1244.3334.934.8733.934.736.2431.2140.53840.337.7926.5645.3143.2856.5252.3141.57
Total Non-Current Liabilities1.13B1.06B1.07B899M895.1M950.4M676.9M723.2M785.1M327.5M338.4M387.6M134.4M127.7M137.2M159.2M119.8M110.5M852.3M905.7M865.8M873.1M636M149.9M131.9M230.5M210.31M146.4M150.4M515.6M
Long-Term Debt784M700.72M770.2M589.9M606.6M646.2M412.1M483.5M647.4M159.9M188.7M250.6M000000731.1M758.3M750.2M750.9M500.8M211.2M4.2M137.4M130.58M131.5M133.5M503.49M
Capital Lease Obligations314.76M155.82M0141.8M127.3M104.1M90.5M87.7M7.2M6.6M00000000000000000000
Deferred Tax Liabilities166.78M41.13M49.4M0000000000013.5M27.6M30.3M28M47.2M63.3M47.5M17.8M23.4M57.2M46.2M41.5M38.64M3.9M8.7M7.1M
Other Non-Current Liabilities303.9M157.61M251.2M167.3M161.2M200.1M174.3M152M130.5M161M149.7M137M134.4M127.7M123.7M131.6M89.5M82.5M74M84.1M68.1M104.4M111.8M-118.5M81.5M51.6M41.09M11M8.2M4.64M
Total Liabilities7.31B4.99B4.09B4.12B3.95B3.2B2.26B2.2B2.41B1.59B1.58B1.52B1.19B1.24B1.34B1.51B1.68B1.63B2.42B2.35B2.59B2.64B2.45B1.67B1.6B1.89B2.47B997.5M777.1M983.2M
Total Debt810.4M914.03M796.7M783.8M786.1M801.8M602.4M710.8M762.3M204.4M244.7M279.7M0055M00222.8M733.1M758.5M750.8M751.4M627.5M3.4M6.9M147.4M131.94M134.2M135.8M519M
Net Debt274.7M319.52M373.4M413.4M411.6M407.8M138.6M231.3M340.3M-310.8M-312.5M-265.6M-565M-544.3M-495.5M-658.9M-632.8M-714.9M-467.9M-358.2M-52.9M-217.6M-341.3M-1.03B-1.84B-1.2B-751.81M-237.3M104.1M413.8M
Debt / Equity0.33x0.41x0.42x0.44x0.47x0.55x0.43x0.52x0.57x0.15x0.19x0.26x--0.04x--0.15x0.54x0.36x0.36x0.34x0.25x0.00x0.00x0.03x0.04x0.08x0.16x1.43x
Debt / EBITDA0.58x0.72x1.06x1.67x1.94x2.73x2.38x2.50x3.90x0.93x1.04x1.52x--0.28x--0.72x2.22x3.20x2.76x2.44x6.78x0.05x0.11x0.55x0.27x0.53x0.96x5.58x
Net Debt / EBITDA0.20x0.25x0.50x0.88x1.02x1.39x0.55x0.81x1.74x-1.41x-1.33x-1.45x-2.88x-2.65x-2.51x-2.37x-2.97x-2.32x-1.41x-1.51x-0.19x-0.71x-3.69x-15.42x-28.11x-4.43x-1.55x-0.94x0.74x4.45x
Interest Coverage21.93x19.69x11.21x4.88x5.62x5.33x3.39x2.95x4.36x14.18x17.30x18.32x41.19x46.07x32.97x37.30x18.30x2.71x-11.38x-----------
Total Equity2.48B2.21B1.9B1.77B1.68B1.46B1.41B1.36B1.33B1.37B1.26B1.09B1.39B1.4B1.32B1.46B1.42B1.48B1.37B2.12B2.09B2.21B2.49B3.47B4.2B4.75B3.47B1.66B859.3M363.2M
Equity Growth %103.99%16.68%7.06%5.56%14.68%3.83%3.89%1.79%-2.77%8.94%15.29%-21.79%-0.51%6%-9.64%2.99%-3.69%8.08%-35.53%1.13%-5.41%-11.03%-28.24%-17.49%-11.42%36.79%109.23%92.96%136.59%-
Book Value per Share21.3419.0415.9714.7213.5711.5510.9110.299.489.448.746.917.737.566.286.716.186.395.969.259.229.7911.2116.0018.2922.1915.929.294.702.75
Total Shareholders' Equity2.48B2.21B1.9B1.77B1.68B1.46B1.41B1.36B1.33B1.37B1.26B1.09B1.39B1.4B1.32B1.46B1.42B1.48B1.37B2.12B2.09B2.21B2.49B3.47B4.2B4.75B3.47B1.66B859.3M363.2M
Common Stock01.62B1.63B1.67B1.71B1.76B1.83B1.83B1.95B2.05B2.05B2.09B2.61B2.71B2.77B03.33B03.59B00000000000
Retained Earnings0407.96M-423.8M-851.8M-1.08B-1.26B-1.37B-1.42B-1.48B-1.53B-1.61B-1.79B-1.85B-1.97B-2.09B-2.2B-2.3B-2.38B-2.44B-1.72B-1.7B-1.55B-1.47B-578.8M-294.7M162.7M217.51M16.2M-52.2M-3.7M
Treasury Stock0-153.52M-92.9M-80.1M-18.5M-48.9M-15.7M-14.8M-20.2M-8.7M-15.3M-31.4M-21.4M-12M-18.3M-37.9M-15.9M-400K000000000000
Accumulated OCI0-1.7M-17.6M-200K-5.7M-26.8M-15.2M-23.6M-26.5M-6.7M-24.7M-32.8M-25M-14.3M4.1M-12.3M59.2M55.8M9.4M59M34.9M27.8M403.3M749.3M827.7M883.9M856.34M-4.1M-57.3M-21.2M
Minority Interest000000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Customer concentration risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Scaling with AI Demand

Total assets surged 58% year-over-year to $9.8B in Q2 2026, according to Celestica's latest balance sheet, driven by a $1.2B PPE expansion and rising receivables, signaling aggressive capacity build-out.

The sequential asset growth of $1.5B from Q1 2026 is the largest in the ten-quarter window, with PPE jumping 39% quarter-over-quarter. This suggests management is front-loading capital to meet hyperscaler demand, but the pace of asset growth may outpace near-term revenue conversion, warranting monitoring of asset turnover. The equity base expanded to $2.5B, reflecting retained earnings accumulation, yet the balance sheet is becoming more asset-heavy, which could pressure returns if growth moderates.

Leverage Creeping Up Despite Low Base

Debt-to-equity rose to 0.33 in Q2 2026 from 0.41 a year earlier, as reported in financial statements, but total debt increased 13% sequentially to $810M, indicating a cautious shift toward debt financing.

While leverage remains conservative relative to peers like Jabil (D/E 2.22) and Flex (0.84), the sequential debt increase of $38M suggests Celestica is beginning to utilize debt to fund capacity expansion. The absolute debt level is modest at 8.3% of total assets, implying ample headroom, but the trend warrants attention if capex needs accelerate. The low leverage provides a buffer against interest rate shocks, yet the rising debt trajectory could signal a strategic pivot from organic cash generation.

Asset Mix Shifts Toward Tangible Capacity

PPE net jumped 39% sequentially to $1.2B in Q2 2026, as per balance sheet data, while goodwill remained flat at $333M, underscoring a pivot toward physical infrastructure over acquisition-driven intangibles.

The sharp PPE increase reflects investment in AI-related manufacturing capacity, aligning with the company's JDM strategy. Goodwill stability suggests organic growth rather than M&A, which reduces impairment risk. However, the rising asset base increases depreciation expense, which could pressure future margins if utilization rates do not keep pace. The asset mix is becoming more capital-intensive, a departure from the asset-light model typical of EMS providers, and may signal a strategic bet on durable AI demand.

Retained Earnings Inflection Supports Equity Quality

Retained earnings swung from -$737.9M in Q1 2024 to $513.2M in Q1 2026, based on reported figures, before a $0 balance in Q2 2026, indicating a dramatic profitability turnaround.

The transition from negative to positive retained earnings over two years reflects sustained profitability, with cumulative net income exceeding prior losses. The Q2 2026 retained earnings balance of $0 is unusual and may indicate a dividend or reclassification, but the prior trajectory suggests strong earnings retention. Equity quality is improving as the company builds internal capital, reducing reliance on external funding. However, the zero balance in Q2 2026 warrants clarification, as it could distort equity composition.

Liquidity Buffer Thins Amid Rapid Growth

Current ratio fell to 1.23 in Q2 2026 from 1.44 a year earlier, as reported in balance sheet data, while cash rose to $535.7M, indicating tighter working capital management despite higher cash reserves.

The declining current ratio suggests that current liabilities are growing faster than current assets, likely due to increased payables and accrued expenses tied to higher revenue. Cash increased 42% sequentially, but the overall liquidity buffer is shrinking relative to short-term obligations. This may indicate efficient working capital management, but it also reduces the cushion against supply chain disruptions. The quick ratio, excluding inventory, would be even lower, highlighting potential vulnerability if inventory becomes obsolete.

Working Capital Distortions Mask True Leverage

The reported D/E of 0.33 understates effective leverage because operating leases and purchase obligations are not included, as per standard accounting, potentially hiding off-balance-sheet commitments.

Celestica's low debt-to-equity ratio is flattered by the exclusion of operating lease liabilities and significant purchase commitments typical in EMS contracts. The company's high-variable-cost model requires substantial inventory and payables, which are not captured in traditional leverage metrics. Investors should monitor off-balance-sheet commitments and the cash conversion cycle, as these could represent hidden claims on future cash flows. The recent working capital swings, as noted in cash flow analysis, suggest that reported leverage may not fully reflect financial risk.

CLS — Frequently Asked Questions

Quick answers to the most common questions about buying CLS stock.

What are the total assets of Celestica Inc. (CLS)?

As of 2025, Celestica Inc. (CLS) had total assets of $7.20B including $5.66B in current assets.

How much debt does Celestica Inc. (CLS) have?

Celestica Inc. (CLS) carries total debt of $914.0M, offset by $594.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Celestica Inc.?

Celestica Inc. (CLS) has total shareholders' equity (book value) of $2.21B ($19.04 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Celestica Inc.'s current ratio and liquidity?

Celestica Inc. (CLS) reported a current ratio of 1.44x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.